What does mrsa do

Cellulitis is a deep skin infection caused by staph or streptococcus strep bacteria, including MRSA. Cellulitis leads to redness, swelling, pain and heat in the skin, sometimes in a large, diffuse area.

Impetigo, a skin infection most commonly seen in children, is usually confined to the upper levels of skin. It can looks very similar to MRSA in some cases, with sores and redness. Impetigo is highly contagious, so you should see a doctor if you suspect either of these conditions. When treated in time, the outlook in most cases is good. Once the infection is resolved, Hultman says it is a good idea to be tested to see if you are a carrier. You can spread MRSA to other people if their skin touches the infected area, so keep the sore bandaged and protected.

Infection with drug-resistant organisms can lead to increased and longer hospital stays, more complicated treatment, more deaths, and higher healthcare costs. As strains of staph continue to adapt and change over time, it is critical for healthcare workers to track these changes.

They need to know which strains are present within a community at any point in time, to which antibiotics the strains are resistant, and the severity of disease caused by the circulating strains. By analyzing strains isolated from these patients, the scientists have found that CA-MRSA accounts for an increasing percentage and number of infections.

This information can help doctors select the optimal antibiotic treatment for infected patients. Scientists would further like to understand the genetic changes in MRSA that allow the bacterium to cause serious illness in otherwise healthy individuals. They chose the USA strain, one of two strains that cause the majority of CA-MRSA cases, because it has emerged as the predominant strain causing skin infections, as well as more serious infections, in both pediatric and adult patients in many states.

Another reason for the interest in the USA strain is that it appears to be more virulent than other strains. Sarah Highlander and Joseph Petrosino and colleagues at the Baylor Human Genome Sequencing Center sequenced the genome of this MRSA-resistant strain from a pediatric patient along with a community-associated staph strain that is susceptible to methicillin.

They then compared the DNA sequences. They also compared the DNA sequence of these strains with the previously published staph genomes of isolates obtained elsewhere. Based on the results of this analysis, the scientists concluded that the USA strain that they sequenced was very similar to other staph strains.

This suggests that the increased virulence of the USA strain is due to subtle genetic changes within its genome. One intriguing finding of their study is that the bacterium has picked up a plasmid that contains a gene that confers resistance to bacitracin, an antibiotic commonly found in over-the-counter skin ointments.

With the genetic information describing USA in hand, the scientists can now zoom in on the regions that differ from other strains to pinpoint genes that may account for the ability of USA to cause serious illness in some people. Beta-lactam antibiotics are the most widely used class of drugs for the treatment of bacterial infections. They include penicillin and its derivatives, such as methicillin and amoxicillin.

The beta-lactam ring portion of the antibiotic targets the penicillin-binding proteins PBP , found in the bacterial cell membrane, which function in the synthesis of the cell wall. Binding of the antibiotic to the PBPs prevents the PBPs from performing their essential role and results in the death of the bacterial cell. Timothy Palzkill , professor of Pharmacology and Chemical Biology and Molecular Virology and Microbiology, and his research team have been studying mechanisms of resistance to methicillin and other beta-lactam antibiotics.

Gram-positive bacteria acquire resistance to beta-lactam antibiotics through the production of a protein called PBP2a, which is able to avoid the inhibitory effects of the antibiotics. They injected the fabrics with colony-forming units of staph and observed the reactions over the following days.

These results demonstrate the need for thorough contact control and meticulous disinfection procedures to limit the spread of bacteria.

MRSA frequently causes illness in people with a compromised immune system who spend time in the hospital and other healthcare facilities.

A person will have a higher risk of developing healthcare-associated MRSA in the hospital if they have had surgery recently or if they have:. MRSA is less common outside a healthcare setting. If it does occur, it is more likely to be a skin infection, although some people develop pneumonia and other infections. People can reduce the risk by practicing appropriate hand washing, keeping wounds clean, avoiding sharing personal items — such as towels and razors, and seeking early treatment if any symptoms of an infection appear.

Children can develop MRSA through an open wound. Find out how to recognize it and what to do. Many people carry MRSA bacteria in their mucosa, for instance, inside the nose, but they may never develop symptoms that indicate an active infection.

Staph skin infections, including MRSA, appear as a bump or sore area of the skin that can resemble an insect bite. The infected area might be :. Symptoms of a serious MRSA infection in the blood or deep tissues may include :.

The following guidelines can help patients, healthcare workers, and visitors prevent MRSA infections from spreading in the hospital:. It may be necessary for a patient with an MRSA infection to stay in their room until treatment is complete. People can reduce the risk of community-associated MRSA outside of hospitals by:.

Experts are concerned about MRSA and other bacteria that have developed resistance to certain antibiotics. However, a growing awareness of hygiene procedures appears to have helped reduce the number of cases. They note that this decrease is probably due to improved guidelines relating to hygiene and contact.

A survey of countries conducted by the World Health Organization finds that only 34 countries have compiled a national action plan to combat…. The world is now on the verge of a 'post-antibiotic era.